chr15-51341922-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181789.4(GLDN):āc.238T>Cā(p.Ser80Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000416 in 1,443,118 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_181789.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLDN | NM_181789.4 | c.238T>C | p.Ser80Pro | missense_variant | 1/10 | ENST00000335449.11 | NP_861454.2 | |
GLDN | XM_017022121.2 | c.238T>C | p.Ser80Pro | missense_variant | 1/9 | XP_016877610.1 | ||
GLDN | XM_017022125.1 | c.238T>C | p.Ser80Pro | missense_variant | 1/10 | XP_016877614.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLDN | ENST00000335449.11 | c.238T>C | p.Ser80Pro | missense_variant | 1/10 | 2 | NM_181789.4 | ENSP00000335196.6 | ||
GLDN | ENST00000558286.5 | n.49T>C | non_coding_transcript_exon_variant | 1/3 | 1 | |||||
GLDN | ENST00000560215.5 | c.124T>C | p.Ser42Pro | missense_variant | 1/4 | 4 | ENSP00000484633.1 | |||
GLDN | ENST00000560690.5 | n.-24T>C | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000416 AC: 6AN: 1443118Hom.: 0 Cov.: 31 AF XY: 0.00000139 AC XY: 1AN XY: 718224
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 07, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at